Marbella

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Familial hypercholesterolaemia2 trials
• Coronary artery disease1 trial
• High blood pressure1 trial
• Pulmonary arterial hypertension1 trial
• Stroke1 trial

Phase

• Phase 1/21 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Novartis Pharmaceuticals3 trials

Running trials

• Active, not recruiting

  Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study

  NCT06958315· Novartis Pharmaceuticals· Source

• Recruiting

  A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

  NCT06649110· Phase 1/2· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals

• Active, not recruiting

  A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

  NCT05739383· Phase 3· Novartis Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• High blood pressure1 recruiting
• Pulmonary arterial hypertension1 recruiting